The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy (2023)

First Author: Banerji C
Attributed to:  Understanding and Ameliorating Pathogenesis in FSHD funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/braincomms/fcad221

Publication URI: http://dx.doi.org/10.1093/braincomms/fcad221

Type: Journal Article/Review

Parent Publication: Brain Communications

Issue: 5